These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7764059

  • 1. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
    Citro G, Ginobbi P, Szczylik C.
    Cytotechnology; 1993; 11 Suppl 1():S30-4. PubMed ID: 7764059
    [Abstract] [Full Text] [Related]

  • 2. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P, Geiser TA, Ombres D, Citro G.
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [Abstract] [Full Text] [Related]

  • 3. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
    Citro G, Ginobbi P, Szczylik C.
    Cytotechnology; 1993 Jan; 11(Suppl 1):S30-4. PubMed ID: 22358703
    [Abstract] [Full Text] [Related]

  • 4. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 5. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP, Cooper SR, Hardee GE.
    Bioconjug Chem; 2003 Sep 14; 14(4):738-47. PubMed ID: 12862426
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G, Szczylik C, Ginobbi P, Zupi G, Calabretta B.
    Br J Cancer; 1994 Mar 14; 69(3):463-7. PubMed ID: 8123474
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
    Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7031-5. PubMed ID: 1495997
    [Abstract] [Full Text] [Related]

  • 8. Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules.
    Rajur SB, Roth CM, Morgan JR, Yarmush ML.
    Bioconjug Chem; 1997 Aug 01; 8(6):935-40. PubMed ID: 9404669
    [Abstract] [Full Text] [Related]

  • 9. Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes.
    Ebbinghaus SW, Vigneswaran N, Miller CR, Chee-Awai RA, Mayfield CA, Curiel DT, Miller DM.
    Gene Ther; 1996 Apr 01; 3(4):287-97. PubMed ID: 8732160
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Epstein Barr Virus LMP1 gene expression in B lymphocytes by antisense oligonucleotides: uptake and efficacy of lipid-based and receptor-mediated delivery systems.
    Galletti R, Masciarelli S, Conti C, Matusali G, Di Renzo L, Meschini S, Arancia G, Mancini C, Mattia E.
    Antiviral Res; 2007 May 01; 74(2):102-10. PubMed ID: 17382835
    [Abstract] [Full Text] [Related]

  • 11. Folate receptor-mediated targeting of liposomal drugs to cancer cells.
    Stephenson SM, Low PS, Lee RJ.
    Methods Enzymol; 2004 May 01; 387():33-50. PubMed ID: 15172156
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor.
    Ou X, Tan T, He L, Li Y, Li J, Kuang A.
    Cancer Gene Ther; 2005 Mar 01; 12(3):313-20. PubMed ID: 15578065
    [Abstract] [Full Text] [Related]

  • 13. Receptor-mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells.
    Madon J, Blum HE.
    Hepatology; 1996 Sep 01; 24(3):474-81. PubMed ID: 8781310
    [Abstract] [Full Text] [Related]

  • 14. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
    Hwa Kim S, Hoon Jeong J, Joe CO, Gwan Park T.
    J Control Release; 2005 Apr 18; 103(3):625-34. PubMed ID: 15820409
    [Abstract] [Full Text] [Related]

  • 15. Aspects of the transport and delivery of antisense oligonucleotides.
    Juliano RL, Yoo H.
    Curr Opin Mol Ther; 2000 Jun 18; 2(3):297-303. PubMed ID: 11249624
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
    Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Müller R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W.
    Bioconjug Chem; 2003 Jun 18; 14(1):158-67. PubMed ID: 12526705
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of Frizzled-10 (FZD10) by beta-estradiol in MCF-7 cells and by retinoic acid in NT2 cells.
    Saitoh T, Mine T, Katoh M.
    Int J Oncol; 2002 Jan 18; 20(1):117-20. PubMed ID: 11743650
    [Abstract] [Full Text] [Related]

  • 19. Controversies in the cellular pharmacology of oligodeoxynucleotides.
    Stein CA.
    Antisense Nucleic Acid Drug Dev; 1997 Jun 18; 7(3):207-9. PubMed ID: 9212912
    [No Abstract] [Full Text] [Related]

  • 20. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
    Weyermann J, Lochmann D, Georgens C, Zimmer A.
    Eur J Pharm Biopharm; 2005 Apr 18; 59(3):431-8. PubMed ID: 15760723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.